GWLLOTCFood and Kindred ProductsFiscal year ends December 31
GOLDENWELL BIOTECH, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.65+0.05 (+8.33%)
Close on Oct 19, 2026
- Market cap
- $64.35M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$55FY2025